FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder/File Photo
FILE PHOTO: A sign marks the headquarters of Moderna in
Reuters | March 27, 2024